Objectives: To develop the European League Against Rheumatism (EULAR) recommendations
for conducting clinical studies and/or clinical trials in systemic vasculitis. Methods: An …

Objectives: We undertook a systematic literature review as a background to the European
League Against Rheumatism (EULAR) recommendations for conducting clinical trials in anti-…

The systemic vasculitides are multisystem disorders with considerable mortality and morbidity
and frequent relapses. In the absence of reliable serological markers, accurate clinical …

Background: Comprehensive multisystem clinical assessment using the Birmingham
Vasculitis Activity score (BVAS) is widely used in therapeutic studies of systemic vasculitis. …

Background Wegener's granulomatosis and microscopic polyangiitis are antineutrophil
cytoplasm antibodies (ANCA)-associated vasculitides with significant morbidity and mortality. …

Objective To develop and validate revised classification criteria for granulomatosis with
polyangiitis (GPA). Methods Patients with vasculitis or comparator diseases were recruited into …

Objective To develop and validate revised classification criteria for eosinophilic granulomatosis
with polyangiitis (EGPA). Methods Patients with vasculitis or comparator diseases were …

Objective To develop and validate classification criteria for microscopic polyangiitis (MPA).
Methods Patients with vasculitis or comparator diseases were recruited into an international …

Background More effective and safer treatments are needed for antineutrophil cytoplasmic
antibody (ANCA)–associated vasculitis. Methods We conducted a randomized trial with a 2-by…

Introduction The previously reported randomised controlled trial of a consensus regimen of
pulse cyclophosphamide suggested that it was as effective as a daily oral (DO) …